Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

IMMUNOHISTOCHEMICAL EXPRESSION OF CORTACTIN AND FOCAL ADHESION KINASE PREDICTS RECURRENCE RISK AND LARYNGEAL CANCER RISK BEYOND HISTOLOGICAL GRADING.

Villaronga MÁ, Hermida-Prado F, Granda-Diaz R, Menendez ST, Alvarez-Teijeiro S, Quer M, Vilaseca I, Allonca E, Garzón-Arango M, Sanz-Moreno V, Astudillo A, Rodrigo JP, García-Pedrero JM.

Cancer Epidemiol Biomarkers Prev. 2018 Apr 13. pii: cebp.1082.2017. doi: 10.1158/1055-9965.EPI-17-1082. [Epub ahead of print]

PMID:
29654156
2.

Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers.

Haigentz M Jr., Suarez C, Strojan P, Rodrigo JP, Rinaldo A, Bradford CR, Corry J, Takes RP, Ferlito A.

Adv Ther. 2018 Mar;35(3):255-260. doi: 10.1007/s12325-018-0682-4. Epub 2018 Mar 6.

PMID:
29511982
3.

Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.

Bäck LJJ, Aro K, Tapiovaara L, Vikatmaa P, de Bree R, Fernández-Álvarez V, Kowalski LP, Nixon IJ, Rinaldo A, Rodrigo JP, Robbins KT, Silver CE, Snyderman CH, Suárez C, Takes RP, Ferlito A.

Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093. [Epub ahead of print]

PMID:
29405536
4.

Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review.

Rodrigo JP, Grilli G, Shah JP, Medina JE, Robbins KT, Takes RP, Hamoir M, Kowalski LP, Suárez C, López F, Quer M, Boedeker CC, de Bree R, Coskun H, Rinaldo A, Silver CE, Ferlito A.

Eur J Surg Oncol. 2018 Apr;44(4):395-403. doi: 10.1016/j.ejso.2018.01.003. Epub 2018 Jan 11. Review.

PMID:
29395434
5.

Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.

Talmi YP, Takes RP, Alon EE, Nixon IJ, López F, de Bree R, Rodrigo JP, Shaha AR, Halmos GB, Rinaldo A, Ferlito A.

Head Neck. 2018 May;40(5):1082-1090. doi: 10.1002/hed.25080. Epub 2018 Feb 2. Review.

PMID:
29394461
6.

Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Rodrigo JP, Manterola L, de Villalaín L, de Vicente JC, Alonso-Durán L, Fernández MP, Lawrie CH, García-Pedrero JM.

Sci Rep. 2017 Dec 19;7(1):17785. doi: 10.1038/s41598-017-18138-8.

7.

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.

Tornin J, Hermida-Prado F, Padda RS, Gonzalez MV, Alvarez-Fernandez C, Rey V, Martinez-Cruzado L, Estupiñan O, Menendez ST, Fernandez-Nevado L, Astudillo A, Rodrigo JP, Lucien F, Kim Y, Leong HS, Garcia-Pedrero JM, Rodriguez R.

Neoplasia. 2018 Jan;20(1):44-56. doi: 10.1016/j.neo.2017.11.004. Epub 2017 Nov 28.

8.

The central compartment - Center of controversy, confusion, and concern in management of differentiated thyroid cancer.

Shaha AR, Silver CE, Angelos P, Nixon IJ, Rodrigo JP, Sanabria A, Vander Poorten V, Williams MD, Rinaldo A, Ferlito A.

Eur J Surg Oncol. 2017 Nov;43(11):1981-1984. doi: 10.1016/j.ejso.2017.08.001. Epub 2017 Aug 12. No abstract available.

PMID:
28916416
9.

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.

Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, Allonca E, Pedregal Mallo D, Astudillo A, García-Pedrero JM.

Sci Rep. 2017 Sep 11;7(1):11110. doi: 10.1038/s41598-017-11709-9.

10.

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

de Bree R, Wolf GT, de Keizer B, Nixon IJ, Hartl DM, Forastiere AA, Haigentz M Jr, Rinaldo A, Rodrigo JP, Saba NF, Suárez C, Vermorken JB, Ferlito A.

Head Neck. 2017 Nov;39(11):2329-2349. doi: 10.1002/hed.24883. Epub 2017 Aug 17. Review.

11.

Prognostic significance of E-cadherin and β-catenin expression in HPV-negative oropharyngeal squamous cell carcinomas.

García-Pedrero JM, García-Cabo P, Ángeles Villaronga M, Hermida-Prado F, Granda-Díaz R, Allonca E, Rodrigo JP.

Head Neck. 2017 Nov;39(11):2293-2300. doi: 10.1002/hed.24897. Epub 2017 Aug 17.

PMID:
28815780
12.

Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Pena-Alonso E, Rodrigo JP, Morgan RO, Granda-Díaz R, Salom C, Fernandez MP, García-Pedrero JM.

Sci Rep. 2017 Jul 28;7(1):6790. doi: 10.1038/s41598-017-07169-w.

13.

Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.

García-Pedrero JM, Martínez-Camblor P, Diaz-Coto S, Munguia-Calzada P, Vallina-Alvarez A, Vazquez-Lopez F, Rodrigo JP, Santos-Juanes J.

J Am Acad Dermatol. 2017 Sep;77(3):527-533. doi: 10.1016/j.jaad.2017.05.047. Epub 2017 Jul 14.

PMID:
28716437
14.

Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.

de Vicente JC, Peña I, Rodrigo JP, Rodríguez-Santamarta T, Lequerica-Fernández P, Suárez-Fernández L, Allonca E, García-Pedrero JM.

Head Neck. 2017 Sep;39(9):1876-1887. doi: 10.1002/hed.24854. Epub 2017 Jul 4.

PMID:
28675642
15.

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).

Mañós M, Giralt J, Rueda A, Cabrera J, Martinez-Trufero J, Marruecos J, Lopez-Pousa A, Rodrigo JP, Castelo B, Martínez-Galán J, Arias F, Chaves M, Herranz JJ, Arrazubi V, Baste N, Castro A, Mesía R.

Oral Oncol. 2017 Jul;70:58-64. doi: 10.1016/j.oraloncology.2017.04.004. Epub 2017 Apr 17. Review.

16.

How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

López F, Williams MD, Cardesa A, Hunt JL, Strojan P, Rinaldo A, Nixon IJ, Rodrigo JP, Saba NF, Mendenhall WM, Quer M, Suárez C, Ferlito A.

Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2709-2726. doi: 10.1007/s00405-017-4533-8. Epub 2017 Mar 31. Review.

PMID:
28364287
17.

Ethical issues in non-intervention trials for thyroid cancer.

Angelos P, Hartl DM, Shah JP, Nixon IJ, Owen RP, Rinaldo A, Rodrigo JP, Shaha AR, Silver CE, Suárez C, Ferlito A.

Eur J Surg Oncol. 2018 Mar;44(3):316-320. doi: 10.1016/j.ejso.2017.03.002. Epub 2017 Mar 16.

PMID:
28343732
18.

The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma.

Gonzalez-Guerrero M, Martínez-Camblor P, Vivanco B, Fernández-Vega I, Munguía-Calzada P, Gonzalez-Gutierrez MP, Rodrigo JP, Galache C, Santos-Juanes J.

J Am Acad Dermatol. 2017 Jun;76(6):1139-1145. doi: 10.1016/j.jaad.2017.01.015. Epub 2017 Mar 14.

PMID:
28314684
19.

How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx?

López F, Williams MD, Skálová A, Hellquist H, Suárez C, Nixon IJ, Rodrigo JP, Cardesa A, Strojan P, Quer M, Hunt JL, Rinaldo A, Ferlito A.

Adv Ther. 2017 Apr;34(4):813-825. doi: 10.1007/s12325-017-0494-y. Epub 2017 Feb 21. Review.

PMID:
28224460
20.

Results of total laryngectomy as treatment for locally advanced hypopharyngeal cancer.

García-Cabo Herrero P, Fernández-Vañes L, López Álvarez F, Álvarez Marcos C, Llorente JL, Rodrigo JP.

Acta Otorrinolaringol Esp. 2017 Nov - Dec;68(6):328-335. doi: 10.1016/j.otorri.2016.11.001. Epub 2017 Jan 19. English, Spanish.

21.

Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.

Sáenz-de-Santa-María I, Bernardo-Castiñeira C, Secades P, Bernaldo-de-Quirós S, Rodrigo JP, Astudillo A, Chiara MD.

Oncotarget. 2017 Feb 21;8(8):13730-13746. doi: 10.18632/oncotarget.14629.

22.

Histological analysis of tonsillectomies: relationship with surgical technique, post-operative pain and haemorrhage.

Magdalena ML, Solé A, Blanco V, Rodrigo JP.

J Laryngol Otol. 2016 Dec;130(12):1142-1146. Epub 2016 Nov 10.

PMID:
27830635
23.

Removing the Taboo on the Surgical Violation (Cut-Through) of Cancer.

Robbins KT, Bradford CR, Rodrigo JP, Suárez C, de Bree R, Kowalski LP, Rinaldo A, Silver CE, Lund VJ, Nibu KI, Ferlito A.

JAMA Otolaryngol Head Neck Surg. 2016 Oct 1;142(10):1010-1013. doi: 10.1001/jamaoto.2016.1826. Review.

PMID:
27468162
24.

HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma.

Fernández-Valle Á, Rodrigo JP, Rodríguez-Santamarta T, Villaronga MÁ, Álvarez-Teijeiro S, García-Pedrero JM, Suárez-Fernández L, Lequerica-Fernández P, de Vicente JC.

Head Neck. 2016 Nov;38(11):1672-1678. doi: 10.1002/hed.24493. Epub 2016 Apr 30.

PMID:
27131339
25.

The impact of family history on non-medullary thyroid cancer.

Nixon IJ, Suárez C, Simo R, Sanabria A, Angelos P, Rinaldo A, Rodrigo JP, Kowalski LP, Hartl DM, Hinni ML, Shah JP, Ferlito A.

Eur J Surg Oncol. 2016 Oct;42(10):1455-63. doi: 10.1016/j.ejso.2016.08.006. Epub 2016 Aug 11. Review.

26.

Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials.

Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Suárez C, Rodrigo JP, Strojan P, Rinaldo A, de Bree R, Haigentz M Jr, Takes RP, Ferlito A.

Auris Nasus Larynx. 2017 Feb;44(1):18-25. doi: 10.1016/j.anl.2016.06.005. Epub 2016 Jul 5. Review.

PMID:
27397024
27.

Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.

Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J, Rodriguez R.

Stem Cells Int. 2016;2016:3631764. doi: 10.1155/2016/3631764. Epub 2016 Jun 5. Review.

28.

Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain.

Rodríguez-Santamarta T, Rodrigo JP, García-Pedrero JM, Álvarez-Teijeiro S, Ángeles Villaronga M, Suárez-Fernández L, Alvarez-Argüelles ME, Astudillo A, de Vicente JC.

Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4549-4559. doi: 10.1007/s00405-016-4152-9. Epub 2016 Jun 24.

PMID:
27342404
29.

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.

García-Carracedo D, Villaronga MÁ, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM.

Oncotarget. 2016 May 17;7(20):29780-93. doi: 10.18632/oncotarget.8957.

30.

Cervical Lymph Node Metastasis in Adenoid Cystic Carcinoma of the Larynx: A Collective International Review.

Coca-Pelaz A, Barnes L, Rinaldo A, Cardesa A, Shah JP, Rodrigo JP, Suárez C, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Wenig BM, Strojan P, Hamoir M, Bradley PJ, Gnepp DR, Silver CE, Slootweg PJ, Triantafyllou A, Vander Poorten V, Williams MD, Skálová A, Hellquist H, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Takes RP, Ferlito A.

Adv Ther. 2016 Apr;33(4):553-79. doi: 10.1007/s12325-016-0311-z. Epub 2016 Mar 19. Review.

31.

Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.

Suárez C, Barnes L, Silver CE, Rodrigo JP, Shah JP, Triantafyllou A, Rinaldo A, Cardesa A, Pitman KT, Kowalski LP, Robbins KT, Hellquist H, Medina JE, de Bree R, Takes RP, Coca-Pelaz A, Bradley PJ, Gnepp DR, Teymoortash A, Strojan P, Mendenhall WM, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Hamoir M, Slootweg PJ, Vander Poorten V, Williams MD, Wenig BM, Skálová A, Ferlito A.

Auris Nasus Larynx. 2016 Oct;43(5):477-84. doi: 10.1016/j.anl.2016.02.013. Epub 2016 Mar 24. Review.

32.

Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review.

Hellquist H, Skálová A, Barnes L, Cardesa A, Thompson LD, Triantafyllou A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suárez C, Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes RP, Rinaldo A, Ferlito A.

Adv Ther. 2016 Mar;33(3):357-68. doi: 10.1007/s12325-016-0298-5. Epub 2016 Feb 19. Review.

33.

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Giefing M, Wierzbicka M, Szyfter K, Brenner JC, Braakhuis BJ, Brakenhoff RH, Bradford CR, Sorensen JA, Rinaldo A, Rodrigo JP, Takes RP, Ferlito A.

Eur J Cancer. 2016 Mar;55:147-57. doi: 10.1016/j.ejca.2015.10.070. Epub 2016 Feb 4. Review.

34.

Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.

Llanos S, García-Pedrero JM, Morgado-Palacin L, Rodrigo JP, Serrano M.

Nat Commun. 2016 Feb 2;7:10438. doi: 10.1038/ncomms10438.

35.

HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.

Menéndez ST, Villaronga MÁ, Rodrigo JP, Álvarez-Teijeiro S, Urdinguio RG, Fraga MF, Suárez C, García-Pedrero JM.

Sci Rep. 2016 Jan 20;6:19666. doi: 10.1038/srep19666.

36.

Cervical lymph node metastases from remote primary tumor sites.

López F, Rodrigo JP, Silver CE, Haigentz M Jr, Bishop JA, Strojan P, Hartl DM, Bradley PJ, Mendenhall WM, Suárez C, Takes RP, Hamoir M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A.

Head Neck. 2016 Apr;38 Suppl 1:E2374-85. doi: 10.1002/hed.24344. Epub 2015 Dec 29. Review.

37.

Expression of the voltage-gated potassium channel Kv3.4 in oral leucoplakias and oral squamous cell carcinomas.

Fernández-Valle Á, Rodrigo JP, García-Pedrero JM, Rodríguez-Santamarta T, Allonca E, Lequerica-Fernández P, de Vicente JC.

Histopathology. 2016 Jul;69(1):91-8. doi: 10.1111/his.12917. Epub 2016 Feb 28.

PMID:
26648458
38.

Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?

Coca-Pelaz A, Devaney KO, Rodrigo JP, Halmos GB, Strojan P, Mendenhall WM, Eisbruch A, Smee R, Kusafuka K, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2925-30. doi: 10.1007/s00405-015-3799-y. Epub 2015 Nov 3. Review.

PMID:
26530293
39.

HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?

Takes RP, Wierzbicka M, D'Souza G, Jackowska J, Silver CE, Rodrigo JP, Dikkers FG, Olsen KD, Rinaldo A, Brakenhoff RH, Ferlito A.

Oral Oncol. 2015 Dec;51(12):1057-60. doi: 10.1016/j.oraloncology.2015.10.011. Epub 2015 Oct 29. Review.

PMID:
26520047
40.

Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.

Rodrigo JP, Menéndez ST, Hermida-Prado F, Álvarez-Teijeiro S, Villaronga MÁ, Alonso-Durán L, Vallina A, Martínez-Camblor P, Astudillo A, Suárez C, María García-Pedrero J.

Sci Rep. 2015 Oct 26;5:15698. doi: 10.1038/srep15698.

41.

Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

Samuels SE, Eisbruch A, Beitler JJ, Corry J, Bradford CR, Saba NF, van den Brekel MW, Smee R, Strojan P, Suárez C, Mendenhall WM, Takes RP, Rodrigo JP, Haigentz M Jr, Rapidis AD, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2877-94. doi: 10.1007/s00405-015-3771-x. Epub 2015 Oct 13. Review.

PMID:
26463714
42.

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.

Ajona D, Pajares MJ, Chiara MD, Rodrigo JP, Jantus-Lewintre E, Camps C, Suarez C, Bagán JV, Montuenga LM, Pio R.

Oral Dis. 2015 Oct;21(7):899-904. doi: 10.1111/odi.12363. Epub 2015 Sep 7.

PMID:
26258989
43.

The role of systemic therapy in the management of sinonasal cancer: A critical review.

Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A.

Cancer Treat Rev. 2015 Dec;41(10):836-43. doi: 10.1016/j.ctrv.2015.07.004. Epub 2015 Jul 31. Review.

PMID:
26255226
44.

Trismus in patients with head and neck cancer: etiopathogenesis, diagnosis and management.

Rapidis AD, Dijkstra PU, Roodenburg JL, Rodrigo JP, Rinaldo A, Strojan P, Takes RP, Ferlito A.

Clin Otolaryngol. 2015 Dec;40(6):516-26. doi: 10.1111/coa.12488. Review.

PMID:
26098612
45.

Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.

Manils J, Gómez D, Salla-Martret M, Fischer H, Fye JM, Marzo E, Marruecos L, Serrano I, Salgado R, Rodrigo JP, Garcia-Pedrero JM, Serafin AM, Cañas X, Benito C, Toll A, Forcales SV, Perrino FW, Eckhart L, Soler C.

Oncotarget. 2015 Sep 8;6(26):22375-96.

46.

Neuroendocrine neoplasms of the sinonasal region.

Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A.

Head Neck. 2016 Apr;38 Suppl 1:E2259-66. doi: 10.1002/hed.24152. Epub 2015 Jul 18. Review.

PMID:
26041714
47.

Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.

Gleber-Netto FO, Braakhuis BJ, Triantafyllou A, Takes RP, Kelner N, Rodrigo JP, Strojan P, Vander Poorten V, Rapidis AD, Rinaldo A, Brakenhoff RH, Ferlito A, Kowalski LP.

Oral Oncol. 2015 Aug;51(8):738-44. doi: 10.1016/j.oraloncology.2015.04.016. Epub 2015 May 16. Review.

PMID:
25987307
48.

Adenoid cystic carcinoma of the head and neck--An update.

Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr, Takes RP, Mondin V, Teymoortash A, Thompson LD, Ferlito A.

Oral Oncol. 2015 Jul;51(7):652-61. doi: 10.1016/j.oraloncology.2015.04.005. Epub 2015 May 2. Review.

PMID:
25943783
49.

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Bonastre E, Verdura S, Zondervan I, Facchinetti F, Lantuejoul S, Chiara MD, Rodrigo JP, Carretero J, Condom E, Vidal A, Sidransky D, Villanueva A, Roz L, Brambilla E, Savola S, Sanchez-Cespedes M.

Cancer Res. 2015 Apr 1;75(7):1287-97. doi: 10.1158/0008-5472.CAN-14-2444.

50.

Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

de Vicente JC, Santamarta TR, Rodrigo JP, García-Pedrero JM, Allonca E, Blanco-Lorenzo V.

Virchows Arch. 2015 May;466(5):549-58. doi: 10.1007/s00428-015-1746-3. Epub 2015 Mar 1.

PMID:
25726183

Supplemental Content

Loading ...
Support Center